申请人:Furuya Shuichi
公开号:US20050101657A1
公开(公告)日:2005-05-12
The present invention provides an androgen receptor antagonistic agent and a superior prophylactic or therapeutic agent for hormone-sensitive cancer, which contain a compound of the formula:
wherein, R
1
is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, R
2
is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, R
3
is a hydrogen atom, a hydrocarbon group which may have substituent(s), an acyl group or a heterocyclic group which may have substituent(s), R
4
is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, and R
5
is a cyclic group which may have substituent(s); or a salt thereof, or its prodrug.
本发明提供了一种雄激素受体拮抗剂,以及一种优越的预防或治疗激素敏感性癌症的药物,其含有式中的化合物:其中,R1是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过硫原子结合的基团,R2是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过硫原子结合的基团,R3是氢原子、可能具有取代基的碳氢基团、酰基或可能具有取代基的杂环基团,R4是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过硫原子结合的基团,R5是可能具有取代基的环状基团;或其盐或前药。